CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 78 enrolled
Drug / intervention
Lithium Carbonate +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02918097
NCT02918097Phase 4Completed
CompareCT.gov

Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode

Federal University of Rio Grande do Sul·interventional·Posted Sep 28, 2016·Updated Nov 20, 2020

In Brief

A Phase 4 clinical trial evaluating Lithium Carbonate, Sertraline, and 2 other interventions for Bipolar Disorder. Completed, enrolled 78 participants.

Detailed Summary

To evaluate the effectiveness of an algorithm for Bipolar Disorder depressive episodes (BDD) using medications available in the Brazilian Public Healthcare System (SUS). Quality of life assessment of these patients was also employed. A randomized pragmatic trial was conducted. An algorithm was developed for the treatment of episodes of bipolar disorder depression episodes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 28, 2016
Enrollment StartMay 1, 2010
Primary CompletionNov 1, 2014
Study CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 9.8 years ago

Interventions

Lithium Carbonatedrug

Sertralinedrug

Nortriptylinedrug

Risperidonedrug